Stay updated on Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has expanded to include 135 locations, and the website has been updated to version 2.10.0, replacing the previous version 2.9.7.
    Difference
    0.3%
    Check dated 2024-07-23T15:37:01.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T08:43:13.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The change in the web page value represents an update to the Erratum information for the study 'Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER)' published in Lancet Oncology. The updated Erratum information includes a new DOI reference: doi: 10.1016/S1470-2045(22)00346-1.
    Difference
    0.1%
    Check dated 2024-07-03T16:12:08.000Z thumbnail image
  8. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-07-02T15:43:49.000Z thumbnail image
  9. Check
    29 days ago
    Change Detected
    Summary
    The value on the web page has recently changed to FDA Safety Alerts and Recalls, indicating a shift in the content focus towards safety alerts and recalls issued by the FDA.
    Difference
    0.1%
    Check dated 2024-06-28T12:44:48.000Z thumbnail image
  10. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-06-27T11:56:37.000Z thumbnail image

Stay in the know with updates to Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.